Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Direct visualization of antigen-specific cytotoxic T cells - a new insight into immune defenses

Article Abstract:

A chemically synthesized compound that looks like an HLA molecule bound to a foreign peptide can be used to directly measure T cells that are targeted to a specific peptide. HLA molecules are molecules that present foreign peptides to T cells so the T cell can kill the organism that produced the peptide. The synthetic version will still bind to T cells that recognize the synthetic peptide. It can be labelled with a fluorescent chemical so the T cells can be counted. This technique can precisely measure the immune response to a specific organism. However, the structure of the peptide must be known.

Author: Schwartz, Robert S.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Measurement, Cell-mediated cytotoxicity, Cell mediated cytotoxicity, CD8 lymphocytes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The hypereosinophilic syndrome and the biology of cancer

Article Abstract:

Some cases of a disease called hypereosinophilic syndrome have a molecular abnormality similar to the one that causes chronic myelogenous leukemia (CML). The molecular abnormality is an enzyme created by a chromosome abnormality. Because the enzyme is similar to the enzyme that causes CML, this type of hypereosinophilic syndrome can be successfully treated with Gleevec.

Author: Schwartz, Robert S.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Genetic aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis

Article Abstract:

A drug called mepolizumab may benefit patients with a skin disease called eosinophilic dermatitis, according to a study of three patients. This drug is a monoclonal antibody against interleukin-5, which is produced in greater than normal amounts in these patients. The drug may benefit patients who do not respond to other drugs used for this disease.

Author: Plotz, Sabine-Gisela, Simon, Hans-Uwe, Darsow, Ulf, Simon, Dagmar, Vassina, Ekatherina, Yousefi, Shida, Hein, Rudiger, Smith, Tim, Behrendt, Heidrun, Ring, Johannes
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Product information, Sweden, Pharmaceutical industry, Skin, Dermatitis, GlaxoSmithKline AB

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drug therapy, Eosinophilia
Similar abstracts:
  • Abstracts: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
  • Abstracts: Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1
  • Abstracts: Identification and distribution of atrial natriuretic polypeptide in ventricular myocardium of humans with myocardial infarction
  • Abstracts: Coeliac disease: maintaining a gluten-free diet. Coeliac disease. What you need to know about Coeliac disease
  • Abstracts: FDA Never Promised an Herb Garden--But Sellers and Buyers Eager to See One Grow. Tensions remain over tPA for stroke
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.